Long-Term Risk for MACE Increased for Children With Hypertension
By Elana Gotkine HealthDay Reporter
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May 6 in JAMA Pediatrics to coincide with the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.
Cal H. Robinson, M.D., from The Hospital for Sick Children in Toronto, and colleagues examined the long-term associated risk for MACE among children with hypertension in a population-based, retrospective cohort study conducted from 1996 to 2022. Data were included for 25,605 children with hypertension compared with 128,025 controls without hypertension matched by age, sex, birth weight, maternal gestational hypertension, prior comorbidities, and a propensity score for hypertension.
The researchers found that the incidence of MACE was 4.6 and 2.2 per 1,000 person-years in children with hypertension and controls, respectively (hazard ratio, 2.1), during a median follow-up of 13.6 years. Higher associated risks for stroke, hospitalization for myocardial infarction or unstable angina, coronary intervention, and congestive heart failure were seen for children with hypertension, but there was no increase in risk seen for cardiovascular death.
"Optimizing the care provided to youth with hypertension may help prevent long-term adult cardiovascular disease, with substantial health and cost-saving benefits," the authors write.
Two authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June...
hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis
THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.